About Courtagen
Courtagen is a company based in Woburn (United States) founded in 2009 by Brian McKernan. It operates as a B2B. Courtagen has raised $41.31 million across 6 funding rounds from investors including Adler & Co., Bunker Hill Capital and First Analysis. The company has 128 employees as of December 31, 2022. Courtagen has completed 1 acquisition, including Medicinal Genomics. Courtagen operates in a competitive market with competitors including Sunbird Bio, BrainSpec, Mursla, Neurovigil and Quadrant Biosciences, among others.
- Headquarter Woburn, United States
- Employees 128 as on 31 Dec, 2022
- Founders Brian McKernan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Courtagen Life Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.31 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jun 12, 2015
-
Investors
Adler & Co.
& 3 more
-
Employee Count
128
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Courtagen
Courtagen has successfully raised a total of $41.31M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $20.0M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Series C - Courtagen | Valuation | Adler & Co , Bunker Hill Capital |
|
| Jun, 2014 | Amount | Series B - Courtagen | Valuation |
investors |
|
| Oct, 2011 | Amount | Series B - Courtagen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Courtagen
Courtagen has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Adler & Co., Bunker Hill Capital and First Analysis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term growth capital is invested in lower middle market companies.
|
Founded Year | Domain | Location | |
|
Venture capital and transaction advisory services for B2B tech companies.
|
Founded Year | Domain | Location | |
|
Tech & Life Science focused early stage VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Courtagen
Courtagen has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medicinal Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of cannabis sequencing services
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Courtagen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Courtagen Comparisons
Competitors of Courtagen
Courtagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sunbird Bio, BrainSpec, Mursla, Neurovigil and Quadrant Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Web-based MRS platform for brain metabolite analysis is utilized.
|
|
| domain | founded_year | HQ Location |
Diagnostic devices for cancer detection are developed using nanostructures.
|
|
| domain | founded_year | HQ Location |
Solution provider for analysis of brain data in medical applications
|
|
| domain | founded_year | HQ Location |
Technologies for the evaluation of brain health and autism spectrum disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Courtagen
When was Courtagen founded?
Courtagen was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is Courtagen located?
Courtagen is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Who is the current CEO of Courtagen?
Brian McKernan is the current CEO of Courtagen. They have also founded this company.
Is Courtagen a funded company?
Courtagen is a funded company, having raised a total of $41.31M across 6 funding rounds to date. The company's 1st funding round was a Series B of $8M, raised on Jun 01, 2010.
How many employees does Courtagen have?
As of Dec 31, 2022, the latest employee count at Courtagen is 128.
What does Courtagen do?
Courtagen, founded in 2009 in Woburn, United States, focuses on providing healthcare solutions, advancing biotech innovations, neurological and metabolic disorders, and therapeutic solutions. Provides solutions for neurological and metabolic disorders. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Who are the top competitors of Courtagen?
Courtagen's top competitors include Sunbird Bio, Mursla and SyntheticMR.
How many acquisitions has Courtagen made?
Courtagen has made 1 acquisition, including Medicinal Genomics.
Who are Courtagen's investors?
Courtagen has 4 investors. Key investors include Adler & Co., Bunker Hill Capital, First Analysis, and Harbor Light Capital Partners.